AI assistant
Sending…
DAVITA INC. — Director's Dealing 2012
Dec 26, 2012
30643_dirs_2012-12-26_c7eb2573-ae32-4235-adfe-87d3e885fff7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2012-12-24
Reporting Person: Kogod Dennis (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-24 | Common Stock | M | 29375 | $63.40 | Acquired | 68562 | Direct |
| 2012-12-24 | Common Stock | F | 16639 | $111.93 | Disposed | 51923 | Direct |
| 2012-12-24 | Common Stock | S | 12736 | $111.0006 | Disposed | 39187 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-24 | Stock Appreciation Right | $63.40 | M | 29375 | Disposed | 2015-03-31 | Common Stock (29375) | Direct |
Footnotes
F1: The range of prices for the sale of these shares was $111.00 - $111.04. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.
F2: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the second anniversary of the grant date, and 8.33% every 3 months thereafter.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25